Literature DB >> 6241788

A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats.

A A Jaffa, J Pratt, A Ashford, G S Bailey.   

Abstract

A time-course study was carried out of the levels of submandibular kallikrein, serum insulin and blood glucose of rats rendered diabetic by alloxan or streptozotocin. The permanent hyperglycemia seen one day after treatment and the subsequent relative changes in the levels of blood glucose recorded over the following nine days were in agreement with previous observations. A significant reduction in the concentration of submandibular kallikrein did not become apparent until ten days following the injection of alloxan or streptozotocin. Thus the enzyme would not appear to have played either a causal or a preventative role in the production of the hyperglycemic state. Furthermore, in disagreement with previous speculation, the submandibular gland had not compensated for the deficiency of insulin with an increase in production of kallikrein. The fall in the level of serum insulin had preceded the decrease in submandibular kallikrein. However, administration of exogenous insulin over a period of three days did not bring about an increase in the concentration of submandibular kallikrein of the diabetic rats. Thus insulin would not seem to be involved in controlling the level of kallikrein in the submandibular gland.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241788     DOI: 10.1007/bf01966759

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Alloxan studies; the action of alloxan homologues and related compounds.

Authors:  G BRUCKMANN; E WERTHEIMER
Journal:  J Biol Chem       Date:  1947-04       Impact factor: 5.157

3.  The effect of alloxan diabetes and insulin in vivo on peroxidase activity in the rat submandibular gland.

Authors:  L C Anderson; B L Shapiro
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

4.  Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.

Authors:  P S Schein; K G Alberti; D H Williamson
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

5.  Peroxidase activity in the developing rat submandibular gland.

Authors:  S Yamashina; T Barka
Journal:  Lab Invest       Date:  1974-07       Impact factor: 5.662

6.  A quantitative study of the levels of glandular kallikrein in normal and diabetic rats.

Authors:  A A Jaffa; Z Rashid; J Pratt; A Ashford; G S Bailey
Journal:  Biochem Med       Date:  1984-02

Review 7.  Biologically active polypeptides in submandibular glands.

Authors:  T Barka
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

Review 8.  Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins.

Authors:  G J Dietze
Journal:  Mol Cell Endocrinol       Date:  1982-02       Impact factor: 4.102

9.  Characterization and origin of immunoreactive glandular kallikrein in rat plasma.

Authors:  W J Lawton; D Proud; M E Frech; J V Pierce; H R Keiser; J J Pisano
Journal:  Biochem Pharmacol       Date:  1981-07-01       Impact factor: 5.858

10.  A possible mechanism of insulin resistance in the rat adipose cell in streptozotocin-induced diabetes mellitus. Depletion of intracellular glucose transport systems.

Authors:  E Karnieli; P J Hissin; I A Simpson; L B Salans; S W Cushman
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more
  1 in total

1.  In vivo secretory responses of submandibular glands in streptozotocin-diabetic rats to sympathetic and parasympathetic nerve stimulation.

Authors:  L C Anderson; J R Garrett; A H Suleiman; G B Proctor; K M Chan; R Hartley
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.